Clinical Trial Update: Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of daily paroxetine at 15 mg and 20 mg for premature ejaculation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: MorePharma Corporation | Conditions: Premature Ejaculation | Phase 3 | Status: COMPLETED